Court documents: AstraZeneca knew about Seroquel diabetes risks in 2000
Pharma Compliance Alert, December 10, 2008
It just got tougher for AstraZeneca to defend itself in lawsuits centering on its antipsychotic drug Seroquel.
Internal company documents shown in federal court last week suggest the company knew about the diabetes risks associated with Seroquel as far back as 2000, according to a Bloomberg article. Portions of the documents were revealed in court during a hearing over the qualifications of expert witnesses the plaintiffs plan to call in a February trial. The complete documents remain under seal at AstraZeneca’s request.
AstraZeneca is facing claims in both state and federal courts and is not the only pharmaceutical manufacturer under fire for its antipsychotic drugs. Thousands of consumers have sued AstraZeneca, Eli Lilly, and Johnson & Johnson, claiming the companies hid side effects of the products and marketed them for off-label uses. So far, Lilly has paid $1.2 billion to settle 31,000 claims by individuals and an additional $62 million to settle claims of improper marketing by 32 states and the District of Columbia.
Comments
0 comments on “Court documents: AstraZeneca knew about Seroquel diabetes risks in 2000 ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Critical Test Results Troubleshooter:
Improve your hospital's system of critical test results (CTR) communication with this handy book and CD-ROM set. It provides...
-
Stark Law, 2nd edition: A user's guide to achieving compliance
This updated version of HCPro's Stark Law best seller, first published in 2005—and now co-authored by former CMS Stark...
-
The Compliance Officer's Handbook, 2nd Edition
This revised edition is packed with even more practical tools, case studies, tips and tools, sample audits, and sample...
-
Occurrence Reporting:
Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Case Management Monthly, March 2012
- Searched